Dr. Michael Stifelman, MD highlights Iris, a 3D modeling tool for minimally invasive kidney procedures. Hackensack Meridian School of Medicine https://lnkd.in/eQZ_mVmA
About us
Urology Times takes the lead in providing news analysis of key advances in surgical and non-surgical techniques, treatments, and practice management. Urology Times has been the #1 read publication for more than 20 years, reaching the full universe of physician-specialists treating urologic disorders. We keep urologists up to date so they can quickly provide better patient care while running a more efficient practice.
- Website
-
http://www.UrologyTimes.com
External link for Urology Times
- Industry
- Book and Periodical Publishing
- Company size
- 51-200 employees
- Type
- Public Company
- Specialties
- Urology
Employees at Urology Times
Updates
-
The FDA has classified the cisplatin drug shortage as resolved, determining that supply of the chemotherapy drug now exceeds demand. https://lnkd.in/ejzvD2nG
FDA marks cisplatin drug shortage as resolved
urologytimes.com
-
The final patient visit has been conducted in a phase 1b trial of the investigational oral compound V117957 in patients with overactive bladder. https://lnkd.in/e35JsiCg
Study progresses of oral compound for overactive bladder
urologytimes.com
-
Data from a phase 2 dose expansion study show encouraging safety and efficacy of IDE397 in patients with MTAP-deletion urothelial carcinoma and non-small-cell lung cancer. https://lnkd.in/eRDkP4sy
IDE397 shows promise in MTAP-deletion urothelial carcinoma
urologytimes.com
-
The FDA has granted a fast track designation to ADI-270 for the potential treatment of pretreated patients with metastatic/advanced clear cell renal cell carcinoma. https://lnkd.in/eAY9X4aH
FDA fast tracks ADI-270 for clear cell renal cell carcinoma
urologytimes.com
-
Dr. Joseph Song discusses Aquablation and the rise in large prostates that he's seen in his practice. https://lnkd.in/ep-9eVp3
Urologist discusses Aquablation, rise in large prostates seen in his practice
urologytimes.com
-
Experts discuss promising developments in the NMIBC space. #blcsm https://lnkd.in/eWYUxABh
Promising Developments in NMIBC
urologytimes.com
-
“We think artificial intelligence has a wide variety of applications that will benefit urologists both in and out of training,” says Dr. Mubashir Shabil Billah. Hackensack Meridian School of Medicine https://lnkd.in/eHVeZ45P
Study assesses quality of ChatGPT-generated summaries of incontinence research
urologytimes.com
-
The FDA has granted a fast track designation to 225Ac-FL-020, an investigational PSMA-targeting radionuclide drug conjugate for mCRPC. https://lnkd.in/ereb53yc
FDA grants fast track designation to 225Ac-FL-020 in mCRPC
urologytimes.com
-
Dr. Aditya Bagrodia discusses tools and resources for surgeons in navigating the emotional impact of surgical complications. https://lnkd.in/eW5Z_cBB
Dr. Bagrodia on tools, resources for surgeons following surgical complications
urologytimes.com